Author: okorie

Forensic evidence does not move directly from an instrument to a courtroom conclusion. Between the raw signal and the final opinion are multiple steps involving specimen selection, analytical chemistry, validation, quality control, statistics, pharmacology, and interpretation. Litigation becomes more precise when those steps are made explicit.

Step One: What Was the Specimen?

Blood, serum, plasma, urine, oral fluid, vitreous humor, hair, and tissue answer different questions. Collection site, container, preservative, storage, freeze-thaw history, contamination, degradation, and postmortem change can all matter. A technically sophisticated interpretation starts with the specimen rather than the final number.

Step Two: What Did the Instrument Actually Measure?

Analytical methods do not simply “find drugs.” They use defined identification criteria and validated procedures. In LC-MS/MS work, retention time, precursor and product ions, ion ratios, calibration, internal standards, blanks, controls, and matrix effects can all be relevant to whether an identification or concentration is supportable.

Technical discussions are available in the research library and at LC-MS/MS Identification Criteria in Forensic Toxicology.

Step Three: How Certain Is the Number?

A reported concentration is not infinitely precise. Calibration model, replicate performance, bias, precision, uncertainty, dilution, reporting limits, and the position of the result within the validated range can affect how much weight a particular number should carry.

See Measurement Uncertainty Near Forensic Toxicology Cutoffs for a focused treatment of this issue.

Step Four: What Does the Concentration Mean?

Interpretation introduces a new layer of inference. The same concentration may have different significance depending on tolerance, route of administration, time since use, active metabolites, co-administered substances, disease, age, specimen type, and whether the case is antemortem or postmortem.

Reference ranges are therefore context, not automatic verdicts. This is particularly important in postmortem cases, where redistribution and sampling site may complicate interpretation.

Step Five: Does the Evidence Support the Ultimate Opinion?

The final question is whether the analytical and interpretive record supports the expert’s courtroom conclusion. “Detected,” “quantified,” “consistent with,” “capable of causing,” “impaired,” and “caused” are not interchangeable statements. Each requires its own evidentiary support.

That distinction is central to the attorney-scientist approach. The task is to identify every inferential step and ask whether the evidence is strong enough to carry the conclusion placed upon it.

Why This Matters in Litigation

Cross-examination is more effective when it follows the science rather than merely attacking credentials. A disciplined review can reveal where the parties agree, where the analytical record is strong, and where an opinion extends beyond what the data establish.

For related legal analysis, see Rule 702 and Forensic Toxicology Expert Testimony. For legal services involving scientific evidence, visit The Okorocha Firm’s Forensic Toxicology & Law practice.

When an expert claims that methamphetamine necessarily worsens performance, the first scientific question is what “performance” means. A claim about every cognitive or psychomotor function is broader than a claim about a particular task.

Two affirmative findings worth examining

Hart and colleagues’ 2008 experiment found improved divided-attention tracking and response latency in experienced methamphetamine users; intermediate doses also improved digit-symbol substitution measures. Kirkpatrick and colleagues’ 2012 comparison found improved divided-attention performance after methamphetamine administration. Neither experiment demonstrated improvement on every tested function. [1,2]

These studies provide a concrete basis for asking an expert to define and support the scope of a claim. The useful question is whether the claimed impairment concerns a function actually measured by the cited research.

Questions that test the scientific reasoning

• Are you claiming impairment of a specific function, or deterioration in every cognitive and psychomotor function?
• Have you considered controlled studies that reported improved tracking speed or response latency after methamphetamine administration?
• Which measured outcome supports your conclusion about this person?
• How do the study participants, administration route, and assessment timing compare with the facts under review?
• Does the research establish the particular real-world activity you are discussing, or only performance on a laboratory task?

Avoid the reverse overstatement

A performance-enhancement finding does not itself prove that an individual was unimpaired. It establishes what happened under the experiment’s conditions. An expert who relies on that result still needs to explain its relevance to the person, activity, and time at issue.

The same discipline applies to both sides of a scientific dispute. An impairment claim should not erase documented improvements; an improvement claim should not erase the boundaries of the experiment. The strongest use of these studies is a precise challenge to an overbroad proposition, followed by an analysis of the actual evidence.

References

1. Hart CL, et al. (2008). Acute Physiological and Behavioral Effects of Intranasal Methamphetamine in Humans. DOI: 10.1038/sj.npp.1301578.
2. Kirkpatrick MG, et al. (2012). Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans. DOI: 10.1111/j.1360-0443.2011.03706.x.

Research summary

A scientific review of experimental research reported modest but meaningful acute impairment in certain driving-related skills associated with THC. Dose, route, recency of use, and tolerance can modify observed effects. CBD’s potential influence on THC-related driving effects remained inconclusive in the reviewed evidence. Expert interpretation should connect the particular task measured to the asserted real-world limitation, rather than equating every cannabinoid detection with a quantified loss of driving ability.

Forensic interpretation

This research describes specific experimental conditions. It does not establish an individual driver’s impairment or the cause of an observed clinical finding without case-specific information. Analytical methodology, timing, dose, route of administration, and plausible alternative explanations should be assessed before making a forensic inference.

Primary research

Read the peer-reviewed research (PMC PMC8106655).

Retrograde alcohol estimation is often presented in litigation as elementary arithmetic: start with a later alcohol concentration, subtract or add a fixed amount per hour, and announce the “BAC at the time.” The mathematics may be simple, but the science is conditional. A defensible opinion depends on whether the person was absorbing, at peak, or eliminating alcohol; whether the drinking history is reliable; and whether the chosen elimination assumptions fit the evidence.

Lim and colleagues published a forensic application of a population pharmacokinetic model in which defendant-specific information was combined with Bayesian estimation. Rather than reporting a single deterministic answer, the authors generated a concentration-time profile with a 95% prediction interval. That approach highlights a central litigation point: uncertainty is not a defect in the science. Concealing uncertainty is.

For counsel examining an alcohol reconstruction, the first question should be whether the expert has identified the phase of the concentration curve. Back-extrapolation is most straightforward only after absorption is substantially complete. If drinking ended near the event, a later specimen may have been collected while the concentration was still rising. In that situation, a simple elimination-rate calculation can overstate confidence and may even infer the wrong directional change.

The second question is the factual foundation. What quantity was consumed? What was the alcohol concentration of the beverages? Over what period? Was food consumed? What is known about body size, sex, relevant physiology, and the specimen collection timeline? Each unsupported input widens the scientifically reasonable range even when the analytical measurement itself is excellent.

The third question is whether the expert has separated model output from observed fact. A measured breath, blood, or serum ethanol concentration is evidence. An estimated earlier concentration is an inference generated from evidence plus assumptions. That distinction should be explicit in the report and in testimony.

Human studies on gastric emptying reinforce why this matters. Alcoholic beverages can slow gastric emptying, and controlled beer studies show that gastric emptying is related to early plasma ethanol response. Those data do not allow a lawyer to calculate a case-specific absorption curve from beverage type alone. They do show why universal assumptions about rapid, complete absorption should be tested against the facts rather than treated as axioms.

A strong expert opinion should therefore disclose the model, assumptions, plausible parameter range, sensitivity to competing drinking histories, and the uncertainty interval. In cross-examination, a single-number conclusion may be less persuasive once the hidden assumptions are made visible.

Attorney-scientists are particularly well positioned to scrutinize that boundary between measurement and inference. The objective is not to make the number larger or smaller. It is to determine how much scientific confidence the evidence actually supports.

Frequently Asked Questions

Is retrograde extrapolation always unreliable?

No. It can be useful when the sampling time and drinking history are sufficiently known and the subject is reasonably established to be post-absorptive. The reliability decreases as those assumptions become uncertain.

Why use a prediction interval?

Because pharmacokinetic parameters and historical inputs vary. A prediction interval communicates the range of concentrations compatible with the model and assumptions rather than creating false precision.

Selected Research

Lim H-S, Soung JH, Bae K-S. Translational and Clinical Pharmacology. 2017. doi:10.12793/tcp.2017.25.1.5.

Kasicka-Jonderko A, et al. Journal of Gastroenterology. 2013. doi:10.1007/s00535-013-0752-y.

Stevens JE, et al. British Journal of Clinical Pharmacology. 2022. doi:10.1111/bcp.15297.